Clark Estates’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Clark Estates's HALO Position: Q3 2026 in Review
Clark Estates reduced its Halozyme (HALO) stake by 34% in Q3 2026, selling an estimated $1.48M and leaving 29,500 shares worth $3.26M. The position accounts for 0.76% of the portfolio, ranked #25.
Clark Estates first reported a position in HALO in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.51M in Q2 2026. 636 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Clark Estates held 29,500 shares of Halozyme worth $3.26M as of Q3 2026.
- Clark Estates sold 15,368 Halozyme shares in Q3 2026, an estimated $1.48M.
- Halozyme made up 0.76% of Clark Estates's portfolio in Q3 2026, its #25 holding.
- Clark Estates first reported a position in Halozyme in Q4 2024 and has held it in 8 quarters since.
- Clark Estates's Halozyme position peaked at $3.51M in Q2 2026.
- 636 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Clark Estates's 13F filing for Q3 2026, filed 10 Nov 2026.